SBI Healthcare Opportunities Fund - Regular Plan -Growth
(Erstwhile SBI Pharma - Regular Plan -Growth)
Fund House: SBI Mutual Fund| Category: Equity: Sectoral-Pharma and Healthcare |
| Launch Date: 14-07-1999 |
| Asset Class: Equity |
| Benchmark: S&P BSE Healthcare TRI |
| TER: 2.09% As on (31-08-2023) |
| Status: Open Ended Schemes |
| Minimum Investment: 5000.0 |
| Minimum Topup: 1000.0 |
| Total Assets: 2,032.95 Cr As on (31-08-2023) |
| Turn over: 50% | Exit Load: Exit load of 0.50% if redeemed within 15 days |
277.6348
2.16 (0.7782%)
14.71%
Benchmark: 13.68%
PERFORMANCE
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
Investment Objective
The scheme seeks maximum growth opportunities through investments in Pharma stocks.
Current Asset Allocation (%)
Indicators
| Standard Deviation | 14.36 |
| Sharpe Ratio | 0.99 |
| Alpha | 3.99 |
| Beta | 0.89 |
| Yield to Maturity | - |
| Average Maturity | - |
PEER COMPARISON
Scheme Characteristics
Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.
Riskometer
PORTFOLIO
Market Cap Distribution
Small Cap
25.94%
Others
9.25%
Large Cap
31.94%
Mid Cap
32.87%
Tax Benefits of investing in this fund
Long term capital gains (LTCG) tax @10% (plus surcharge, if applicable and cess) without indexation if units held for more than 12 months#
Short term capital gains (STCG) tax @ 15% (plus surcharge, if applicable and cess) if units are held for less than 12 months.
Investor does not pay any tax on dividends but a Dividend Distribution Tax (DDT) is deducted at source @11.648% (10% + 12% surcharge + 4% Health & education cess) **
# Capital gain accrued up to January 31st 2018 is exempt from LTCG tax in respect of units acquired before January 31, 2018 & redeemed on or after April 1, 2018. ** The DDT is to be paid by the mutual fund
